Not Found
Locations

Find information on medical topics, symptoms, drugs, procedures, news and more, written for the health care professional.

Gerstmann-Sträussler-Scheinker Disease (GSS)

(Gerstmann-Sträussler-Scheinker's Disease)

By Pierluigi Gambetti, MD, Professor and Director, National Prion Disease Pathology Surveillance Center, Institute of Pathology, Division of Neuropathology, Case Western Reserve University

Click here for
Patient Education

Gerstmann-Sträussler-Scheinker disease is an autosomal dominant prion brain disease that typically begins during middle age.

GSS occurs worldwide and is about 100-fold less common than Creutzfeldt-Jakob disease (CJD). It develops at an earlier age (40 vs 60 yr), and average life expectancy is longer (5 yr vs 6 mo).

Patients have cerebellar dysfunction with unsteady gait, dysarthria, and nystagmus. Gaze palsies, deafness, dementia, parkinsonism, hyporeflexia, and extensor plantar responses are also common. Myoclonus is much less common than in CJD.

GSS should be considered in patients with characteristic symptoms and signs and a family history, particularly if they are 45 yr. Genetic testing can confirm the diagnosis.

There is only supportive treatment for GSS.